results to I earnings since is Thanks, good call, line The through first afternoon, quarter outlook XXXX. to my call to on commentary for everyone. the Orthofix we'll remaining before today's Doug around over agenda our the strategic to aspects transitioning President our today call top CEO. walk key our provide plan, after plus which appreciate you and discuss Mark, handing us of joining fourth the and results financial
Orthofix, industry distributor with global as our significant and customers, partners many well I joining surgeon administrators. Since teams spent time as
conversations, result a enthusiastic us front more these before of the opportunity I'm I about even As of the joined than company. in
growth and enhance is have extremity There First correction and/or we course, foremost, based market of leadership stimulation, around us for allografts, bone in and technology offerings. opportunity strong positions and, cellular cervical well-defined to artificial these build deformity disc. significant
purchase cervical here gratitude the limb for positions recently am external excited have collectively, and most be we patience period very my products, will company leading quiet both offering the these are our up addition, to options, comprehensive the say, length announced amplify how to the only of Orthofix with I'd we express delivered this of I be and offering In you've internal for asset and of call. to the size. like company Needless at impressive FITBONE, a to during
strategic a to During company's take to accelerated and current strategic create this next assess the growth been prepare to and with plan time, the working level. we've key status initiatives Orthofix
pleased this I'm about investment, company that these talk initiatives While we some the can happen these take to overnight, fund execute and certain will fully won't I'm objectives, transformation on can I'm to and about. say
by a and we business at programs, Orthofix ordered the across future. collectively With in like legal, I developed solid that cash at thank all our all strategic support to creating strengths, been all the at team would talented great enthusiasm technology has foundation seen in a and levels. the positioned can to at accounting, and product into as our done strong finance, job compliance which I've grow. we take spirit from is and commercially. team well to successfully the Orthofix Orthofix geographies, company the infrastructure, from execute the Apart everyone business Orthofix I've personally for plan units their impressed
where commercial on opportunity performance Now to see to results. I our financial improve areas and substantial let's move
discussed distraction third the quarter quarter, As the discuss the earnings challenges in Spine on impacted the departures with from we leadership over bit. combined CEO fourth some business of the the a will these I as call, carried over year, negatively last in into performance, transition, our
leadership of to remind strategic like Spine Bone XXXX I'd occurred, implementing think a However, and and unit the were legacy Spinal -- to biologics, motion Therapies, I the businesses into Growth departures we leadership. preservation Implants while everyone to important Global a business initiative it's that also realign single
As a lack of deal clear and of great result, a we forward. organizational uncertainty path experienced a
you So of strategic in tell and and execution, me outline the plan. key strategic development. let new to X investment I'm and commercial about are going channel innovation operational product which leadership, focus, areas procedural structure
which focused and structure initiative, is I'll leadership. with first start on strategic our
with the vacancies talented early have leadership between businesses a some will organization. to since and In while team realignment announced been me adding focus huge Filling complete of revenue to and business some Spine our across these our to previously we pleased coordination has I I'm efforts our arrived, terms of you for progress. share and the improve maximize businesses, our to of unit focus seek Extremity to we structure, entire
Global Let Kevin high-performance expertise new many President Kevin his Biologics and has successful and expertise. career. considerable Spine. Kenny, has and me Spine of teams throughout start our built general commercial with He has management
successful in will In give knowledge, Spine his a us skills, spine and fact, channel in creation and of market believe marketplace. and I key the relationships advantage channel of he huge combination was the at leadership the built expertise that Biologics, Medtronic's spine. team most largest part the sales
in bolstering with commercializing experts as foremost Senior entire We and have in consider Motion progress career I one of Spine, has products Kevin's Joe Vice spine addition Preservation. procedures. spent also made in Joe great of Ross President the team him and the of Spine his
market. first in disc lumbar of the of United most experience join think where product in the He's disc. next-generation can significant disc launch States, Spine, commercial disc our Joe has artificial was at the and he cervical most Joe recently, he Importantly, we the he artificial then to on the in part discs. artificial to took sought-after generate and team, LDR success excited fastest-growing the is the
Medtronic significant similar Another team held addition Kosters, Vice who recently and to at the Spine of and Senior Director us NuVasive comes is as to Spine. joined Biologics. Managing Paul Paul having President and Spine roles International
international and experience significant relationships a have opportunity in and We markets our potential. maximize their Paul's will
filling Spinal of our VP are position. to We Sales U.S. close
to number opportunity at for the candidates have I'm based out spine identified We opportunity. on looking leaders have pleased a me others directly of candidates new excellent report Orthofix. these to and experienced a reached are
are team leadership spine and very have about have I'm Spine building. experience These done this before. excited tremendous the executives we
just We this are already and beginning. I making is the a know big impact,
our accelerate Nephew high-performance a in an level, been our execution flawless operational have hired as global seek operation Extremities been new of has excellence, To we created Zimmer created similar He a in group in Regulatory executive Verona, promoted existing product and Wright Esmail capacities. Previously, managing culture Smith XXXX, At introductions. to Affairs a Biomet, our business Ehab Head the he newly experienced at previously has built build med was Italy, Quality, role. tech & globally. operations is corporate Clinical who he newly has and truly Roberto group, embodies support Global and to starting where into Donadello our worked and
I streamlined forward Taking position our talent execute will is Orthofix the new segue look us for second success, roles, combining initiative, will That to the structure. operational them and additions coalescing us team we within with our strategic new and into as existing strong this which execution. commercially
to customers how products our they win when they that we and To primarily it. is tissue entails means pretty me, want our and want and this supply ensuring optimizing obvious The get high-quality it chain.
on the down agile, benefits an and my aggressive, financial on road, focused creating is have will this winning. execution immediate culture, flawless competitive focus While
important How products a is service, their as aim have tissues will customer. when. to by our be We customer defined market-driven customers which as our want just and
direction. customers focus many forward. physicians, hospital are us passionate include about, who their our going assist administration very future patients, and is I'm will We and discussions views, in This defining to payers in currently on understand and with something
view that experience. at everyone owns Orthofix total the customer the creating are We
today over there developing market that are tell you are going require high-value needs move competitive for Having our how let's and is initiative, innovation trends creating it solutions on third how disruptive unmet both markets that strategic to be know solve been unmet which solutions. product orthopedics our Those I technologies. procedure is products and these call laser-focused and Now are, difficult spine develop to differentiation. and We're that on XX acquiring years, needs. and the can you that of to in
in we spine this pipeline It on you bulk focused our research not requires As over of fully the these will term. plan. executing new a later, see but about is and some rebuilding to discuss in few talk the development the past We've easy will short takes initiatives product years is and time. invested the innovation, investments
and our product expectations As leaders development it cycle, the the the alignment will focus engagement, done extremity intense with delivery innovation redefining groups talent thought spine around changing we on accelerating of world. used, processes be with and additions,
our invest regulatory launch to new clinical opportunity. MX-C the also two-level future and will of our expand We execution with in study our market
extremity businesses planned. are in studies Additional and spinal also our
good In of our where products be recently that disciplined and well, assets value. in as fit Both Kinetics inorganic the price a acquirers add FITBONE, cases, an fits, looking we discuss can that strategic value. we acquired can as significant moment, we are examples On acquisition that are on. to that and types of execute to will at and we will continue strong of portfolio purchase of Orthofix of I a Spinal strengthen reasonable the acquisition significant both front, well add announced have our deals
future. of believe revenue significant also in acquisitions We will that the drive both these
announced spend as area for is an a nail I'd sharing the to deformity my technology, been recently market platform. to Now along excitement asset a clearly moment lengthening strategic highly offering we company the and extremities about agreement where technology this This the limb external acquire options, our correction. angular to the for our This only with in want eight-Plate be portfolio. both leadership. correction With we'll a maintain has us deformity internal FITBONE lengthening gap is like pediatric
the preoperative the it. for we the procedures is product their take which our extremity to implant complex has motorized HEX-RAY in We'll offering FITBONE the technology about TL-HEX and simpler excited While market, patients. FITBONE only used into these its integrate work very make our one software, we our to order of products, are in planning active can where kind currently surgeons
scoliosis nail, FITSPINE. FITBONE the lengthening to called is addition there In a application technology
this, and along us care $XXX regulatory future While deformity for estimate today, and platform years the come. for this efforts applications, technology about the use clinical technology high have only at with to single by opportunity early digits, for X penetrated very the competitor. growing X/X roughly market about are in We million the excited
$X only technology this to future. believe we expect we from will generate in for While sales FITBONE million us be the XXXX, in revenue the contribution approximately significant
these of $XX We almost assets $X excludes million. will benefit for tax which a purchase million,
expect Doug we to deal will later, As million touch dilutive $X be adjusted bit to XXXX approximately on a EBITDA. in this
close expect XXXX. of late to the March transaction We in
commercial Lastly, and definitely channel. our our is fourth initiative least, not strategic
With the Extremity commercial created intend and channels. Spine to have we in transform our invest and in both leadership we teams businesses,
partners developing and XX differentiation synergies our Orthofix growth sell to months, These vision This the us our realize long-term multiple focus Over adding growth. or product is lines strategic share across product for partnerships. enable will and next to on and sustained inherent lines. will plan realize our
to aligned grow The collectively sides. is trust, Whether agnostic reps, both on stocking agents, long are sales term. be over That our commitment together from deal commercial highly great this and we At fundamental focus are thread our model. we that sales direct a businesses the our talent. distributors to it requires on expectations or point, is of partners delivering to
initiatives, strategic have ahead we As significant execute X we work us. on of our we know
at looking some Here and metrics goals be are XXXX. for we'll tangible
side, must the set Spine availability and reduce sales to business our the we goal execution, Sales new the With time tend fill new and supply to differentiation, our our continue our chain and development of the operational to product for organization. to and to respect is organic for leadership, vacancy to Construction we innovation VP of implement structure. a improvements transition product implement process. on lead In
time, Our is increase objective concept-to-commercialization of our introductions. to new while the increasing reduce product volume
inorganic initiate side, acquisition On we close the the expect to FITBONE integration. and
of number initiative, selling Biologics by increase the For our commercial channel intend Extremity to we XX%. distributors
of number one the by in X%. product increase U.S. carry target our will our to than spine we more addition, In lines sales distributors of
I effort that performance time to will levels, more expected on require updating reach to our forward our and areas you and have progress. than others We look
quarter results which range. Now grew the us at trends the the low let's performance. illustrated fourth end basis, the constant in Overall, of quarter sales guidance shift and continuation discuss caused the of third X.X%. a to from the currency quarter, of a On we our come
distraction which by offset by revenue the business year. was segment, from MX-C prior growth our the launch. In growth changes structure Revenue Spine muted and driven transition, the success was over the by of U.S. Global decreased X.X% leadership
was the mostly Let in channel are business was down color key our on due now the backfilled. little end me a with commercial distributors, This normal at Growth loss you a which at being product Therapies, key our X.X%, X the of and churn provide Bone to of Starting each low expectations. families. of was year-over-year which
We reflect this disruption, have sales stabilization. and XXXX rectify steps early to taken
However, be XXXX. the business gradual I recovery do in very this expect to throughout
notice would address I to the Today, on meeting advisory devices. respect like reclassified in coming published, an a devices XX our class to may this April medical panel announcing also as stimulator committee Class Bone some you registry, about Therapy growth consider to weeks. whether Federal of Growth II the from an questions in should to have business, with FDA III bone item be
Class in that for status products. safety efficacy these and, convened recall reasons maintain ultimately, to may of FDA the You and determine panel a XXXX, III
in submit these other of devices to stimulators, participate in that in our order efficacy manufacturers We, remain therapy. confident We the testimony. position growth and should of be III very to class together continue ensure with the will hearing bone
bone expand range devices in Orthofix wave BGS to has cervical investing company use. symmetries. encompass the the indications intended stimulation studies a platform. and we design only are parameters, We FDA, growth by enjoy uses, functionalities, indication market-leading and the the only ID technologies, dose of for distinct granted
not Given of set the dissimilarities (k) stated, among of could distinct devices, single assure XXX safety type of -- BGS device. with the reasonably these of special devices of and Simply a are the nature not controls controls. effectiveness even BGS and each special
In growth Now let's driving constant were with move for the sales back Implants, performance. to Spinal in up year MX-C Implant over currency the Spinal prior X.X% sales U.S. quarter.
spine void In sales in driven constant detail the products, in Fixation, more were new which prior Spine product down of little sales distributors a you give leadership. me Let currency around over X.X% performance by ramp-up Spinal year, and Implants. core our in hardware continued was the slow
with As significant this business have on team, mentioned earlier, the understanding attention current new good of a and tenured spine dynamics. our we have
of for future feel success currently are plan crafting this and about business. We a the positive
million finished the over Moving grew $X.X the for U.S. Motion currency prior at on to sales year to the XX.X% due U.S. year. Preservation, success launch. sales constant our of guidance above
continue can are propel the We adoption team to what early to do excited very the and new about trajectory. the
this focus and technology. ensure education training our of continuing long-term are success novel to We on
we of growth. with were after deceleration tougher quarter distributors year-over-year A in solid headwinds expect We given of the anniversary progress XXXX. this the that XXXX, quarters comps efforts. demonstrated from as continuation quarter into to previous was our fourth a added In do due realignment X.X% the some Biologics, we for business of
on. ELITE Trinity tissue, I partnership, have strong to the with a and Biologics However, the we solid platform MTF build believe
roll ELITE, Additionally, continue these contribute out the characteristics over we like years. continue handling sales Trinity coming to with should to which fiberFUSE DBM
buoyed X.X% in a currency offset of was competitive quarter. Trinity offering ELITE, portfolio and at the customers. tender, Global international during Our our sales needs the by our U.S. constant Extremities which This large surgeon by built grew the meets In weakness around was this segment, Biologic
currency trailing X.X%. revenue The XX-month constant growth was
the While Doug, financial relieve materially guidance. and the the the I XXXX in certain experiencing will competitive in performance over FITBONE contribute having With been to around acquisition call commentary XXXX, is the of hand quarter's pressure now not to available that, further geographies. we've expected will for some product
